This inventor holds 4 USPTO granted patents. Top assignees: Washington University, Chiba University. Active years: 2007-2015.
Company Filing History:
Years Active: 2007-2015
Title: Norihiko Watanabe: Innovator in Lymphocyte Modulation
Introduction
Norihiko Watanabe is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of immunology, particularly in the modulation of lymphocyte activity. With a total of 4 patents to his name, Watanabe's work has the potential to impact therapeutic approaches for autoimmune diseases.
Latest Patents
Watanabe's latest patents include innovative methods and compositions for modulating lymphocyte activity. One notable invention is a novel lymphocyte inhibitory receptor termed BTLA, which is expressed on both T and B cells. This invention identifies HVEM as interacting with BTLA and provides methods for modulating BTLA-mediated signaling. Additionally, he has developed a method for identifying compounds that can prevent or treat autoimmune diseases. This method involves obtaining a BTLA NKT cell from a non-human animal and testing various compounds to measure their effects on the cell's response to antigens.
Career Highlights
Throughout his career, Watanabe has worked with esteemed institutions such as Washington University and Chiba University. His research has focused on understanding the mechanisms of immune response and developing therapeutic strategies to enhance or inhibit these responses.
Collaborations
Watanabe has collaborated with notable colleagues, including Theresa L. Murphy and Jianfei Yang. These collaborations have further enriched his research and contributed to advancements in the field of immunology.
Conclusion
Norihiko Watanabe's innovative work in lymphocyte modulation showcases his dedication to advancing medical science. His patents and research have the potential to lead to significant breakthroughs in the treatment of autoimmune diseases.